Coverage of intermittent preventive treatment of malaria in pregnancy (IPTp) influences delivery outcomes among women with obstetric referrals at the district level in Ghana

listen audio

Study Justification:
– The study aimed to determine the coverage of intermittent preventive treatment of malaria in pregnancy (IPTp) and its relationship with delivery outcomes among obstetric referral cases at the district level of healthcare in Ghana.
– The study focused on women with obstetric referrals, which is a unique aspect compared to previous studies that have looked at all pregnant women in general.
– The findings of the study provide valuable insights into the importance of adequate IPTp coverage in improving delivery outcomes among women with obstetric referrals.
Study Highlights:
– The study was conducted in three districts in the Greater Accra region of Ghana from May 2017 to January 2018.
– A total of 460 obstetric referrals from 16 lower level facilities who delivered at the three district hospitals were included in the analysis.
– Only 48.5% of the referrals received adequate (at least 3) doses of IPTp.
– Factors such as the district, type of facility where antenatal care (ANC) is attended, insurance status, marital status, and number of ANC visits significantly affected IPTp doses received.
– Adequate IPTp coverage was significantly associated with improved delivery outcomes, including reduced newborn complications, low birth weight, preterm delivery, and malaria as an indication for referral.
– The study highlights the need to facilitate IPTp service delivery to pregnant women across the country, improve coverage of required doses, and maximize the benefits to both mothers and newborns.
Recommendations:
– Increase awareness and education about the importance of IPTp among healthcare providers, pregnant women, and the general public.
– Strengthen the healthcare system to ensure the availability and accessibility of IPTp services in all districts.
– Improve inter-facility communication and referral systems to ensure timely and appropriate care for pregnant women with obstetric referrals.
– Enhance health insurance coverage to reduce financial barriers to accessing IPTp services.
– Conduct further research to explore strategies for improving IPTp coverage and delivery outcomes among pregnant women.
Key Role Players:
– Ministry of Health: Responsible for policy development and implementation of interventions related to malaria prevention in pregnancy.
– National Malaria Control Program: Provides technical guidance and support for malaria prevention and control efforts, including IPTp.
– District Health Directorate: Oversees healthcare delivery at the district level and coordinates implementation of interventions, including IPTp.
– Healthcare Providers: Responsible for delivering IPTp services and providing antenatal care to pregnant women.
– Community Health Workers: Play a crucial role in educating and mobilizing pregnant women to access IPTp services.
– Non-Governmental Organizations: Support implementation of malaria prevention programs and provide resources for IPTp service delivery.
Cost Items for Planning Recommendations:
– Training and capacity building for healthcare providers on IPTp guidelines and service delivery.
– Procurement and distribution of sulfadoxine-pyrimethamine (SP) for IPTp.
– Development and dissemination of educational materials and awareness campaigns.
– Strengthening inter-facility communication systems, including infrastructure and technology.
– Monitoring and evaluation of IPTp coverage and delivery outcomes.
– Research and data analysis to inform evidence-based interventions.
– Coordination and collaboration between different stakeholders involved in malaria prevention in pregnancy.
Please note that the cost items provided are general categories and not actual cost estimates. The actual costs may vary depending on the specific context and implementation strategies.

The strength of evidence for this abstract is 7 out of 10.
The evidence in the abstract is moderately strong. The study conducted a cross-sectional analysis of data on intermittent preventive treatment of malaria in pregnancy (IPTp) coverage and delivery outcomes among obstetric referral cases in three districts in Ghana. The study found that adequate IPTp coverage was associated with improved delivery outcomes. However, the study has limitations such as missing data and the focus on referred pregnant women, which may not reflect the situation for the entire pregnant women population. To improve the strength of the evidence, future studies could include a larger sample size and a more diverse population of pregnant women to increase generalizability. Additionally, addressing the issue of missing data and conducting longitudinal studies could provide more robust evidence.

Background: The aim of the study was to determine the coverage of intermittent preventive treatment of malaria in pregnancy (IPTp) and its relationship with delivery outcomes among obstetric referral cases at the district level of healthcare. Methods: An implementation research within three districts of the Greater Accra region was conducted from May 2017 to February 2018, to assess the role of an enhanced inter-facility communication system on processes and outcomes of obstetric referrals. A cross-sectional analysis of the data on IPTp coverage as well as delivery outcomes for the period of study was conducted, for all the referrals ending up in deliveries. Primary outcomes were maternal and neonatal complications at delivery. IPTp coverage was determined as percentages and classified as adequate or inadequate. Associated factors were determined using Chi square. Odds ratios (OR, 95% CI) were estimated for predictors of adequate IPTp dose coverage for associations with delivery outcomes, with statistical significance set at p = 0.05. Results: From a total of 460 obstetric referrals from 16 lower level facilities who delivered at the three district hospitals, only 223 (48.5%) received adequate (at least 3) doses of IPTp. The district, type of facility where ANC is attended, insurance status, marital status and number of antenatal clinic visits significantly affected IPTp doses received. Adjusted ORs show that adequate IPTp coverage was significantly associated with new-born complication [0.80 (0.65-0.98); p = 0.03], low birth weight [0.51 (0.38-0.68); p < 0.01], preterm delivery [0.71 (0.55-0.90); p = 0.01] and malaria as indication for referral [0.70 (0.56-0.87); p < 0.01]. Positive association with maternal complication at delivery was seen but was not significant. Conclusion: IPTp coverage remains low in the study setting and is affected by type of health facility that ANC is received at, access to health insurance and number of times a woman attends ANC during pregnancy. This study also confirmed earlier findings that, as an intervention IPTp prevents bad outcomes of pregnancy, even among women with obstetric referrals. It is important to facilitate IPTp service delivery to pregnant women across the country, improve coverage of required doses and maximize the benefits to both mothers and newborns.

At delivery, a cross-sectional analysis of data for obstetric referrals which ended in deliveries in three districts/municipalities in the Greater Accra region of Ghana from May 2017 to January 2018 was conducted. This study was part of an implementation research to evaluate the role of an enhanced inter-facility communication system on the processes and outcomes of obstetric referrals in these districts in the region. The Greater Accra region hosts Ghana’s capital city and has 20 administrative metropolises, municipalities, districts and sub-metropolises. It is mostly urban but has 4 rural districts. The study was conducted in Ga West which is semi-urban and Ada East and Ningo-Prampram which are largely rural. Two of the selected districts (Ada East and Ga West) have district hospitals while one (Ningo-Prampram) has a polyclinic as the highest-level public facility. It however has a private hospital where patients are referred to, which is included in this study. A small number of patients are also referred outside the district, (but were not included in the sample). Participants were pregnant women who had been referred from lower levels of care (health center, polyclinic, community clinic and community health and planning services [CHPS] compounds), within the district to the district hospital, and received care at the district hospital, over the period from May 2017 to January 2018, and delivered before discharge. These women, who were already part of a larger study, were included in this study because It was possible to analyse the pregnancy outcome as well as the IPTp doses and other related factors at one point in time without the need to follow them up. A facility audit was conducted to, among other things, assess the availability of sulfadoxine-pyrimethamine (SP) at pharmacy or dispensary as well as stock-out of SP at the pharmacy or dispensary within 6 months prior to and at the time of the study. The availability of a laboratory that offers malaria testing services was determined. Participants answered a questionnaire while on admission, and their records as well as hospital registers were also reviewed during the period of stay in hospital for additional data using a checklist. Data was collected on participants’ sociodemographic characteristics, previous pregnancy history, current pregnancy details, indication for referral and delivery factors. The primary outcome variables were any maternal complication at delivery and any new-born complications at delivery. Secondary outcomes were gestational age, birth weight and anaemia at delivery, gender of baby and whether malaria was the indication for the referral. Focus was not on complications during the whole pregnancy period because participants had been referred and most of them had one complication or the other before delivery. Independent variables were dose of IPTp received during pregnancy and others shown in Table 1. For analysis of relationship between IPTp coverage and delivery outcomes, IPTp doses received was categorized as adequate or inadequate based on the WHO recommendation of at least 3 doses during pregnancy [16], Definition of variables for the study Gestational age at delivery: preterm ( 40 weeks) Haemoglobin level at delivery: Normal (≥ 12 g/dl), mild anaemia (10.0–11.9 g/dl), moderate anaemia (9.9–7.0 g/dl) severe anaemia (< 7.0 g/dl) Birth weight of baby: Low birth weight ( 4.0 kg) Dose of IPTp received during pregnancy: 0, 1–3, 4–5, > 5; Adequate (NMCP/WHO): (5 +)/(3 +), Inadequate (NMCP/WHO): (< 5)/(< 3) ANC antenatal care, IPTp intermittent presumptive treatment of malaria in pregnancy Total missing data were more than 5% and this level of missing data is rarely random. Thus, multiple imputations of missing data were conducted and analysis was based on the imputed data set. Descriptive analysis using frequencies and proportions was done for all the independent and outcome variables. Bivariate analysis using χ2 test was used to investigate the relationship between the IPTp dose coverage and other independent variables, with detection of significance set at p < 0.05. Using a backward stepwise approach, a model was built with all the significant factors in the χ2 analysis to determine the predictors of IPTp dose coverage. For analysis of association between IPTp coverage and outcomes, IPTp doses received was categorized as adequate or inadequate based on the WHO recommendation of at least 3 doses during pregnancy [16]. Associations between IPTp dose coverage and the outcomes were estimated using odds ratios (OR), with their 95% confidence intervals (CI). Significance tests were based on Wald Chi square tests and p-values < 0.05 were considered significant, with all potential confounders adjusted for. Data analysis was carried out using IBM SPSS Statistics for Windows, Version 20.0. Armonk, NY: IBM Corp. The strength of this paper is in the fact that it focused on women with obstetric referrals and not all pregnant women in general as most studies have looked at. Most of these women have some pregnancy complication and yet the data shows that adequate IPTp coverage is associated with improved delivery outcomes among them. Patient records for data on the IPTp coverage and some of the secondary outcome variables were used, leading to some missing data. This is a limitation of the study which was addressed by doing multiple imputation of data for the analysis. Also, it must be noted that this work was done among referred pregnant women and so results may not reflect what the situation is for the entire pregnant women population.

N/A

Based on the provided information, here are some potential innovations that could be recommended to improve access to maternal health:

1. Strengthening inter-facility communication system: Enhance the communication channels between lower-level healthcare facilities and district hospitals to ensure seamless referral processes for pregnant women with obstetric complications. This can include the use of telemedicine, mobile applications, or dedicated hotlines for timely and efficient communication.

2. Increasing availability of sulfadoxine-pyrimethamine (SP): Ensure that district hospitals and lower-level healthcare facilities have an adequate supply of SP, which is used for intermittent preventive treatment of malaria in pregnancy (IPTp). This can be achieved through improved procurement and supply chain management systems.

3. Training healthcare providers: Provide comprehensive training to healthcare providers on the importance of IPTp and its proper administration. This can help increase awareness and knowledge among healthcare providers, leading to improved coverage and adherence to IPTp guidelines.

4. Community engagement and education: Conduct community awareness campaigns to educate pregnant women and their families about the benefits of IPTp and the importance of attending antenatal care (ANC) visits regularly. This can help increase demand for ANC services and improve IPTp coverage.

5. Health insurance coverage: Explore options to improve access to health insurance for pregnant women, as insurance status was found to significantly affect IPTp doses received. This can involve expanding existing health insurance schemes or implementing targeted insurance programs for pregnant women.

6. Integration of services: Integrate IPTp services with other maternal health interventions, such as antenatal care and delivery services, to provide a comprehensive package of care for pregnant women. This can help streamline service delivery and ensure that pregnant women receive all necessary interventions in a coordinated manner.

7. Monitoring and evaluation: Establish robust monitoring and evaluation systems to track IPTp coverage and delivery outcomes. This can help identify gaps and challenges in service delivery and inform targeted interventions to improve access to maternal health services.

It is important to note that these recommendations are based on the specific context and findings of the study mentioned. Further research and contextual analysis may be required to tailor these recommendations to specific settings and populations.
AI Innovations Description
Based on the provided description, the recommendation to improve access to maternal health and address the low coverage of intermittent preventive treatment of malaria in pregnancy (IPTp) in Ghana is as follows:

1. Strengthen ANC services: Enhance the availability and accessibility of antenatal care (ANC) services in both urban and rural areas of Ghana. This can be achieved by increasing the number of health facilities offering ANC, improving the quality of care provided, and ensuring that pregnant women have easy access to these services.

2. Increase awareness and education: Implement comprehensive health education programs to raise awareness among pregnant women about the importance of IPTp in preventing malaria during pregnancy. This can be done through community outreach programs, health campaigns, and the use of mass media to disseminate information.

3. Improve supply chain management: Ensure a consistent and reliable supply of sulfadoxine-pyrimethamine (SP), the recommended drug for IPTp, in health facilities. Strengthen the supply chain management system to prevent stock-outs and ensure that SP is readily available for pregnant women who require it.

4. Enhance inter-facility communication: Establish and strengthen communication systems between lower-level health facilities and district hospitals to facilitate the referral process for pregnant women with obstetric complications. This will ensure that pregnant women are promptly referred to higher-level facilities where they can receive appropriate care, including IPTp.

5. Address financial barriers: Explore options to reduce financial barriers that prevent pregnant women from accessing ANC services and receiving the recommended doses of IPTp. This can include expanding health insurance coverage for pregnant women, providing subsidies for ANC services, and implementing targeted interventions to support vulnerable populations.

6. Monitor and evaluate: Establish a robust monitoring and evaluation system to track the coverage and effectiveness of IPTp interventions. Regularly assess the implementation of IPTp guidelines, identify gaps, and make necessary adjustments to improve the delivery of services and outcomes.

By implementing these recommendations, it is expected that access to maternal health, specifically the coverage of IPTp, will be improved in Ghana, leading to better delivery outcomes and improved health for both mothers and newborns.
AI Innovations Methodology
Based on the provided information, here are some potential recommendations to improve access to maternal health:

1. Strengthening ANC services: Enhance antenatal care (ANC) services by ensuring that all pregnant women have access to comprehensive and quality care. This includes regular check-ups, health education, and screening for potential complications.

2. Increasing IPTp coverage: Implement strategies to improve the coverage of intermittent preventive treatment of malaria in pregnancy (IPTp). This can be achieved through training healthcare providers, ensuring the availability of necessary medications, and raising awareness among pregnant women about the importance of IPTp.

3. Enhancing inter-facility communication: Improve communication systems between lower-level healthcare facilities and district hospitals to facilitate timely and efficient obstetric referrals. This can help ensure that pregnant women with complications receive appropriate care in a timely manner.

4. Expanding health insurance coverage: Increase access to health insurance for pregnant women to reduce financial barriers to maternal healthcare services. This can be achieved through government initiatives, subsidies, or partnerships with private insurance providers.

To simulate the impact of these recommendations on improving access to maternal health, a methodology could include the following steps:

1. Define the target population: Identify the specific group of pregnant women who would benefit from the recommendations, such as those with obstetric referrals in the Greater Accra region of Ghana.

2. Collect baseline data: Gather information on the current status of access to maternal health services, including IPTp coverage, ANC utilization, inter-facility communication, and health insurance coverage. This can be done through surveys, interviews, or analysis of existing data.

3. Develop a simulation model: Create a mathematical or statistical model that represents the relationships between the recommendations and the outcomes of interest, such as maternal and neonatal complications, birth outcomes, and IPTp coverage. The model should consider factors such as the population size, resource availability, and the impact of each recommendation on the outcomes.

4. Input data and run simulations: Input the baseline data into the simulation model and run multiple simulations to estimate the potential impact of implementing the recommendations. Vary the parameters and assumptions to explore different scenarios and assess the robustness of the results.

5. Analyze and interpret results: Analyze the simulation results to determine the potential improvements in access to maternal health services and the associated outcomes. Assess the statistical significance and magnitude of the effects of each recommendation.

6. Communicate findings and make recommendations: Present the simulation results in a clear and concise manner, highlighting the potential benefits of implementing the recommendations. Use the findings to inform policy decisions, program planning, and resource allocation to improve access to maternal health services.

It is important to note that the methodology for simulating the impact of recommendations may vary depending on the specific context and available data. It is recommended to consult with experts in the field of maternal health and implementation research to ensure the accuracy and validity of the simulation methodology.

Share this:
Facebook
Twitter
LinkedIn
WhatsApp
Email